About 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (PubChem CID 167256651) has the molecular formula C67H79F2N15O13S2
and a molecular weight of 1404.59 g/mol. Its IUPAC name is 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.
Frequently Asked Questions
What is the IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The IUPAC name of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (CID 167256651) is 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.
What is the SMILES notation for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The canonical SMILES for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is C[C@@]12CCCN1C(O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)[C@H](Cc1c[nH]c3ccc(F)cc13)NC(=O)CNC(=O)[C@H](CCN)NC(=O)CCSCc1cccc(c1)CSC[C@@H](C(N)=O)NC2=O.
What is the InChIKey of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The InChIKey is IWSSZLXMUJAMPE-YUMHZURNSA-N. The full InChI is InChI=1S/C67H79F2N15O13S2/c1-67-16-3-18-84(67)65(96)54(21-36-6-10-44(85)11-7-36)82-63(94)52(26-43-30-72-35-76-43)80-64(95)53(27-58(88)89)81-62(93)51(23-40-29-74-48-13-9-42(69)25-46(40)48)79-61(92)50(22-39-28-73-47-12-8-41(68)24-45(39)47)78-57(87)31-75-60(91)49(14-17-70)77-56(86)15-19-98-32-37-4-2-5-38(20-37)33-99-34-55(59(71)90)83-66(67)97/h2,4-13,20,24-25,28-30,35,49-55,65,73-74,85,96H,3,14-19,21-23,26-27,31-34,70H2,1H3,(H2,71,90)(H,72,76)(H,75,91)(H,77,86)(H,78,87)(H,79,92)(H,80,95)(H,81,93)(H,82,94)(H,83,97)(H,88,89)/t49-,50-,51-,52-,53-,54-,55-,65?,67-/m0/s1.
What are the key properties of 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid has a molecular weight of 1404.59 g/mol, XLogP of 1.19, 13 rotatable bonds, 16 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5R,8S,14S,17S,20S,23S,26S,32S)-32-(2-aminoethyl)-5-carbamoyl-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-13-hydroxy-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-8-methyl-7,16,19,22,25,28,31,34-octaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is sourced from PubChem (CID 167256651), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).